REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 219 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
| Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
| First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
| Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
| MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
| Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
| Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
| Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
| KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
| Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |
| Perceptive Advisors | 670,206 | $68,334,204 | 1.98% |
| LBJ Family Wealth Advisors, Ltd. | 25,604 | $2,611 | 1.81% |
| Ikarian Capital, LLC | 110,000 | $11,215,600 | 1.79% |
| HighMark Wealth Management LLC | 21,219 | $2,163,489 | 1.63% |
| Integral Health Asset Management, LLC | 120,000 | $12,235,200 | 1.52% |
| EMERALD ADVISERS, LLC | 317,096 | $32,331,108 | 1.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 255,387 | $26,039,259 | 1.41% |
| Soleus Capital Management, L.P. | 97,547 | $9,945,892 | 1.11% |
| MADDEN SECURITIES Corp | 21,000 | $2,141,160 | 1.10% |
| Harvest Investment Services, LLC | 18,655 | $1,902,064 | 1.08% |
External links
This page lists REATA PHARMACEUTICALS INC's shareholders in Q2 2023. To view REATA PHARMACEUTICALS INC's shareholder history, click here.